Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-versus-Host Disease

Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease

Bone Marrow Transplantation volume 41, pages 293–302 (2008)Cite this article

Abstract

We investigated the effect of 0.05% topical cyclosporine (Cys) on the ocular surface and tear functions in dry eye patients with chronic GVHD (cGVHD) in a prospective comparative study. Thirty eyes of 15 patients refractory to baseline treatment were recruited and the patients assigned for topical Cys treatment group (14 eyes of 7 patients) and control group (12 eyes of 6 patients) respectively. Two patients dropped out because of intolerable irritation while using topical Cys eye drops. Visual analog scale symptom scores, corneal sensitivity, Schirmer I test value, tear film break-up time (TBUT), tear evaporation rate and ocular surface vital staining scores were recorded at baseline and at the end of the following one month. Conjunctival impression and brush cytology were performed before and after the treatment. After topical Cys treatment, significant improvements were found in symptom scores, corneal sensitivity, tear evaporation rate, TBUT, vital staining scores, goblet cells density, conjunctival squamous metaplasia grade, inflammatory cell numbers and the MUC5AC expression. Our study suggests that 0.05% topical Cys may be an effective treatment for dry eye patients with cGVHD. The improvements in the ocular surface and tear functions resulted presumably from the decreased inflammation, increased goblet cell density and MUC5AC mRNA expression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Article 15 September 2022

Pavel Kolkhir, Ana M. Giménez-Arnau, … Marcus Maurer

Article 30 November 2023

Eleni Stamellou, Claudia Seikrit, … Rafael Kramann

References

  1. Horowitz M . Uses and growth of hematopoietic cell transplantation immunology. In: Blume KG, Forman SJ, Applebaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell: Malden, MA, 2004, pp 9–15.

    Google Scholar 

  2. Martin PJ . Overview of hematopoietic cell transplantation. In: Blume KG, Forman SJ, Applebaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell: Malden, MA, 2004, pp 16–30.

    Google Scholar 

  3. Ogawa Y, Kuwana M . Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003; 22: S19–S27.

    Article  PubMed  Google Scholar 

  4. Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW . Ocular manifestations of graft-vs-host disease. Ophthalmology 1983; 90: 4–13.

    Article  CAS  PubMed  Google Scholar 

  5. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after hematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125–1130.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW . The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 1983; 101: 580–584.

    Article  CAS  PubMed  Google Scholar 

  7. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  PubMed  Google Scholar 

  8. Mencucci R, Rossi Ferrini C, Bosi A, Volpe R, Guidi S, Salvi G . Ophthalmological aspects in allogenic bone marrow transplantation: Sjogren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 1997; 7: 13–18.

    Article  CAS  PubMed  Google Scholar 

  9. Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European group for blood and marrow transplantation (EBMT) Working party on late effects. Bone Marrow Transplant 1996; 17: 1105–1111.

    CAS  PubMed  Google Scholar 

  10. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31: 579–583.

    Article  CAS  PubMed  Google Scholar 

  11. Murphy PT, Sivakumaran M, Fahy G, Hutchinson RM . Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Bone Marrow Transplant 1996; 18: 641–642.

    CAS  PubMed  Google Scholar 

  12. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA . GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000; 25: 1101–1103.

    Article  CAS  PubMed  Google Scholar 

  13. Ogawa Y, Okamoto S, Kuwana M, Mori T, Watanabe R, Nakajima T et al. Successful treatment of dry eye in two patients with chronic graft versus host disease with systemic administration of FK506 and corticosteroids. Cornea 2001; 20: 430–434.

    Article  CAS  PubMed  Google Scholar 

  14. Sall K, Stevenson OD, Mundorf TK, Reis BL . Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107: 631–639.

    Article  CAS  PubMed  Google Scholar 

  15. Stevenson D, Tauber J, Reis BL . Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cyclosporin A phase 2 study group. Ophthalmology 2000; 107: 967–974.

    Article  CAS  PubMed  Google Scholar 

  16. Barber LD, Pflugfelder SC, Tauber J, Foulks GN . Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology 2005; 112: 1790–1794.

    Article  PubMed  Google Scholar 

  17. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K . Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology 1998; 105: 1485–1488.

    Article  CAS  PubMed  Google Scholar 

  18. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005; 139: 242–246.

    Article  PubMed  Google Scholar 

  19. Tsubota K, Yamada M . Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992; 33: 2942–2950.

    CAS  PubMed  Google Scholar 

  20. Goto E, Endo K, Suzuki A, Fujikura Y, Matsumoto Y, Tsubota K et al. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2003; 44: 533–539.

    Article  PubMed  Google Scholar 

  21. Toda I, Tsubota K . Practical double vital staining for ocular surface evaluation. Cornea 1993; 12: 366–367.

    Article  CAS  PubMed  Google Scholar 

  22. Nelson JD . Impression cytology. Cornea 1988; 7: 71–81.

    Article  CAS  PubMed  Google Scholar 

  23. Dogru M, Asano-Kato N, Tanaka M, Igarashi A, Shimmura S, Shimazaki J et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res 2005; 30: 897–908.

    Article  CAS  PubMed  Google Scholar 

  24. Miyoshi T, Fukagawa K, Shimmura S, Fujishima H, Takano Y, Takamura E et al. Interleukin-8 concentrations in conjunctival epithelium brush cytology samples correlate with neutrophil, eosinophil infiltration, and corneal damage. Cornea 2001; 20: 743–747.

    Article  CAS  PubMed  Google Scholar 

  25. Pflugfelder SC . Anti-inflammatory therapy of dry eye. Ocul Surf 2003; 1: 31–36.

    Article  PubMed  Google Scholar 

  26. Nishida T . Neurotrophic mediators and corneal wound healing. Ocul Surf 2005; 3: 194–202.

    Article  PubMed  Google Scholar 

  27. Kunert KS, Tisdale AS, Gipson IK . Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002; 120: 330–337.

    Article  CAS  PubMed  Google Scholar 

  28. Wilson SE, Perry HD . Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Ophthalmology 2007; 114: 76–79.

    Article  PubMed  Google Scholar 

  29. Tatlipinar S, Akpek EK . Topical cyclosporin in the treatment of ocular surface disorders. Br J Ophthalmol 2005; 89: 1363–1367.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Rao SN, Rao RD . Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Cornea 2006; 25: 674–678.

    Article  PubMed  Google Scholar 

  31. Lelli Jr GJ, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI et al. Ophthalmic cyclosporine use in ocular GVHD. Cornea 2006; 25: 635–638.

    Article  PubMed  Google Scholar 

  32. Ogawa Y, Kuwana M, Yamazaki K, Mashima Y, Yamada M, Mori T et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003; 44: 1888–1896.

    Article  PubMed  Google Scholar 

  33. Ogawa Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, Ishida S et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42: 111–119.

    CAS  PubMed  Google Scholar 

  34. Duncan N, Craddock C . Optimizing the use of cyclosporin in allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 38: 169–174.

    Article  CAS  PubMed  Google Scholar 

  35. Tsubota K, Fujita H, Tadano K, Takeuchi T, Murakami T, Saito I et al. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Invest Ophthalmol Vis Sci 2001; 42: 101–110.

    CAS  PubMed  Google Scholar 

  36. Tsubota K, Saito I, Ishimaru N, Hayashi Y . Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model. Invest Ophthalmol Vis Sci 1998; 39: 1551–1559.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have no proprietary interest in any of the products mentioned in the manuscript. Presented in part at the 60th Japan Congress of Clinical Ophthalmology, 5–8 October 2006, Kyoto, Japan in the same name as this manuscript, ‘’Ocular Surface and Tear Functions after Topical Cyclosporine Treatment in Dry Eye Patients with Chronic Graft-Versus-Host Disease'. Work supported by a grant from the Japanese Ministry of Education, Science, Sports and Culture #18591932. Dr Wang and Dr Ogawa contributed equally to the current work and should be considered of double first authors.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan

    Y Wang, Y Ogawa, M Dogru, M Kawai, Y Tatematsu, M Uchino, N Okada, A Igarashi, A Kujira, H Fujishima, J Shimazaki & K Tsubota

  2. Department of Ophthalmology, Eye and ENT Hospital of Fudan University School of Medicine, Shanghai, China

    Y Wang

  3. J & J Ocular Surface and Visual Optics Department, Keio University School of Medicine, Tokyo, Japan

    Y Wang & M Dogru

  4. Department of Ophthalmology, Tokyo Dental College, Chiba, Japan

    M Dogru & J Shimazaki

  5. Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    S Okamoto

Authors
  1. Y Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Dogru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Tatematsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Uchino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Igarashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Kujira
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H Fujishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J Shimazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K Tsubota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Ogawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Ogawa, Y., Dogru, M. et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 41, 293–302 (2008). https://doi.org/10.1038/sj.bmt.1705900

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705900

Keywords

This article is cited by

Search

Advanced search

Quick links